Page last updated: 2024-08-25

drospirenone and Hyperandrogenism

drospirenone has been researched along with Hyperandrogenism in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (43.75)	29.6817
2010's	9 (56.25)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Canu, E; Fulghesu, AM; Melis, F; Melis, GB; Murru, G	1
Karaca, Z; Kelestimur, F; Unluhizarci, K	1
Busacca, M; De Cicco, S; Gagliano, D; Guido, M; Lanzone, A; Romualdi, D	1
Caruso, S; Cianci, A; Cianci, S; Cicero, C; Lo Presti, L; Malandrino, C	1
Bottiglieri, P; Colao, A; Colarieti, G; Giallauria, F; Muscogiuri, G; Orio, F; Palomba, S; Predotti, P; Savastano, S; Tafuri, D	1
Bilchugova, E; Colonna, L; Guardianelli, F; Lello, S; Pallotta, P; Primavera, G; Raskovic, D; Sorge, R; Vittori, G	1
Colonna, L; Guardianelli, F; Lello, S; Primavera, G; Raskovic, D; Sorge, R; Vittori, G	1
Cianci, A; De Leo, V; Di Sabatino, A; Morgante, G; Musacchio, MC; Petraglia, F; Scolaro, V	1
Colonna, L; Guardianelli, F; Lello, S; Melis, GB; Pacifico, V; Paoletti, AM; Primavera, G; Raskovic, D; Sorge, R	1
Arslanian, S; Lee, S; Sutton-Tyrrell, K; Tfayli, H; Ulnach, JW	1
Biringer, K; Biringerová, Z; Svecová, I; Visnovský, J	1
de Zegher, F; Ibáñez, L	2
Cabré, S; De Zegher, F; Ibáñez, L; Valls, C	1
Cianci, A; De Leo, V; Morgante, G; Musacchio, MC; Petraglia, F; Piomboni, P	1
Rich, P	1

Reviews

1 review(s) available for drospirenone and Hyperandrogenism

Article	Year
Hormonal contraceptives for acne management. Cutis, 2008, Volume: 81, Issue:1 Suppl Topics: Acne Vulgaris; Androstenes; Clinical Trials as Topic; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Skin	2008

Trials

9 trial(s) available for drospirenone and Hyperandrogenism

Article	Year
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study. Journal of endocrinological investigation, 2013, Volume: 36, Issue:8 Topics: Adolescent; Adult; Androstenes; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Combinations; Ethinyl Estradiol; Female; Glucose Clamp Technique; Hirsutism; Humans; Hyperandrogenism; Pilot Projects; Polycystic Ovary Syndrome; Triglycerides	2013
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial. Clinical endocrinology, 2016, Volume: 85, Issue:5 Topics: Adult; Androstenes; Cardiovascular Diseases; Carotid Intima-Media Thickness; Contraceptives, Oral; Ethinyl Estradiol; Exercise; Female; Humans; Hyperandrogenism; Metabolic Diseases; Polycystic Ovary Syndrome; Risk Factors; Young Adult	2016
Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2008, Volume: 24, Issue:12 Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Androstenedione; Androstenes; Chlormadinone Acetate; Dehydroepiandrosterone Sulfate; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hair; Humans; Hyperandrogenism; Luteinizing Hormone; Sex Hormone-Binding Globulin; Skin Diseases; Testosterone; Young Adult	2008
Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome. Contraception, 2010, Volume: 82, Issue:3 Topics: Adolescent; Adult; Androstenedione; Androstenes; Chlormadinone Acetate; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Norpregnenes; Polycystic Ovary Syndrome; Progesterone Congeners; Sex Hormone-Binding Globulin; Statistics, Nonparametric; Testosterone; Young Adult	2010
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors. The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:5 Topics: Adolescent; Adrenocorticotropic Hormone; Androstenes; Body Composition; Cardiovascular Diseases; Double-Blind Method; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hemodynamics; Hormones; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Overweight; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Stimulation, Chemical; Thiazolidinediones	2011
[Hormonal treatment effectivity in hyperandrogenic syndrome]. Ceska gynekologie, 2010, Volume: 75, Issue:5 Topics: Adult; Androgen Antagonists; Androstenes; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Syndrome	2010
Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:4 Topics: Adiponectin; Adipose Tissue; Adolescent; Adult; Androgen Antagonists; Androstenes; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Flutamide; Hormone Antagonists; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Intercellular Signaling Peptides and Proteins; Interleukin-6; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Proteins	2004
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide. The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:9 Topics: Adiponectin; Adolescent; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Intercellular Signaling Peptides and Proteins; Interleukin-6; Lipolysis; Metformin; Polycystic Ovary Syndrome; Proteins	2004
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy. The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:1 Topics: Adolescent; Adult; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Lipolysis; Metformin; Polycystic Ovary Syndrome; Time Factors	2005

Other Studies

6 other study(ies) available for drospirenone and Hyperandrogenism

Article	Year
Very low dose of flutamide in the treatment of hyperandrogenism. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:5 Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Androstenes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Hyperandrogenism; Norpregnenes; Treatment Outcome; Young Adult	2018
Hirsutism - from diagnosis to use of antiandrogens. Frontiers of hormone research, 2013, Volume: 40 Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Spironolactone	2013
Hyperandrogenic women treated with a continuous-regimen oral contraceptive. European journal of obstetrics, gynecology, and reproductive biology, 2013, Volume: 171, Issue:2 Topics: Acne Vulgaris; Adolescent; Androgens; Androstenes; Contraceptives, Oral, Combined; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone	2013
[Effect on skin and hormonal hyperandrogenic manifestations of an oral estroprogestin association containing ethynilestradiol 30 mg and drospirenone 3 mg]. Minerva ginecologica, 2008, Volume: 60, Issue:3 Topics: Adolescent; Adult; Androstenes; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Norpregnenes; Severity of Illness Index; Skin; Treatment Outcome	2008
[Short-term effect of an estroprogestin containing ethinylestradiol 20 mcg + drospirenone 3 mg in 24+4 regimen at hormonal and cutaneous level in ovarian hyperandrogenism]. Minerva ginecologica, 2010, Volume: 62, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Androstenes; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Norpregnenes; Severity of Illness Index; Time Factors; Treatment Outcome	2010
Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome. Fertility and sterility, 2007, Volume: 88, Issue:1 Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Prospective Studies	2007